- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Retroperitoneal haemorrhage in renal angiomyolipoma causing hepatic functional decompensation: a case report
© Wajed et al; licensee BioMed Central Ltd. 2007
Received: 28 June 2007
Accepted: 06 September 2007
Published: 06 September 2007
Renal angiomyolipomata usually present as incidental findings on routine imaging, but rarely they may give rise to significant haemorrhage. If bleeding occurs, first-line treatment is currently angiography with selective embolisation. Prophylactic embolisation may be considered in some cases, depending on lesion size and patient co-morbidities.
We present a case of retroperitoneal bleeding from a renal angiomyolipoma in a patient with known cirrhosis of the liver, which caused acute deterioration of liver function and consequent hepatic encephalopathy. Selective embolisation of the lesion was performed with a good subsequent outcome. Such functional hepatic decompensation has not previously been reported in this context and we suggest the use of prophylactic embolisation for incidental renal angiomyolipomata, regardless of size, in all patients with chronic liver disease to prevent this potentially life-threatening complication.
Renal angiomyolipomata are incidental findings that usually remain clinically silent in the majority of cases . However, in a small minority there have been reports of severe haemorrhage, which can be fatal if not treated promptly [2–6].
There is a strong association with angiomyolipomata and tuberous sclerosis [2, 4, 7]. However, there are no case reports of renal angiomyolipomata in patients with chronic liver disease and the potential hepatic complications, if there is a spontaneous haemorrhage [8–10].
There is an established risk of sudden bleeding from angiomyolipomata in lesions greater than 4 cm in maximal diameter, or during pregnancy from an increased haemodynamic flow. In some countries this has led to prophylactic embolisation beginning to become the recommended practice in such cases [4–6, 11].
This case report demonstrates the rare complication of a bleeding renal angiomyolipoma in association with chronic liver disease, which caused rapid decompensation and encephalopathy. We suggest the use of prophylactic embolisation of incidental angiomyolipomata, regardless of size, in all patients with chronic liver disease.
A 59 year-old woman presented to her general practitioner in 2005 with a 2-month history of right-sided flank pain, haematuria, and weight loss. She was not diabetic or dyslipidaemic, and there was no significant past medical or family history. She did not take any medications and denied any significant alcohol consumption, cigarette smoking or a history of illicit intravenous drug usage.
Examination revealed hepatomegaly with tenderness in the right upper quadrant. There was no evidence of jaundice, ascites or hepatic encephalopathy and rest of system examinations were normal.
Initial blood tests revealed abnormal liver function tests (LFTs), with alanine aminotransferase (ALT) 38 u/L (normal range: 5–40 u/L), alkaline phosphatase (ALP) 142 u/L (normal range: 20–120 u/L), bilirubin 35 mmol/L (normal range < 17 mmol/L), and gamma glutamyl transferase (GGT) 335 (normal range: < 55 u/L). Her prothrombin time was not significantly prolonged at 12.1 s (normal range 9.6–11.6 s).
In view of the above, she was referred to our hospital for further investigations. Additional blood tests included an autoimmune antibody screen, serum copper, caeruloplasmin, alpha-1- antitrypsin and serum ferritin levels, which were all normal. Hepatitis virology and serum tumour markers were also all negative.
Magnetic resonance (MR) of the abdomen confirmed an enlarged liver with hypertrophy of the caudate lobe and numerous focal nodules, likely to represent regenerative nodules. There was also evidence of chronic pancreatitis, and the appearance of a right-sided renal angiomyolipoma was confirmed.
An ultrasound-guided liver biopsy was performed. Histology from this revealed appearances of cirrhosis, although no specific underlying cause was evident. As a result, she was diagnosed as having compensated 'cryptogenic' cirrhosis of the liver, with chronic pancreatitis and a right-sided renal angiomyolipoma.
A year later, she was admitted through the accident and emergency department with vomiting, fever and severe back pain, radiating down both legs. She denied any passage of melaena, rectal bleeding or haematemesis and there were no obvious precipitating causes for her symptoms.
On examination she appeared pale, jaundiced and there was a marked postural drop in her blood pressure. She was tender in the right upper abdominal quadrant and right loin, with hepatomegaly and gross ascites.
Blood tests revealed a 3 g/dL drop in haemoglobin to 8.6 g/dL and worsening LFTs (ALT 55 u/L, bilirubin 48 mmol/L and GGT 478 u/L). Arterial blood gases showed a high anion gap with metabolic acidosis and respiratory compensation. Her prothrombin time was slightly elevated at 13.1 s with an APTT at the upper end of the normal range at 31.8s (normal range 24–32 s) and a normal fibrinogen level at 2.53 g/L (normal range 1.8–3.6 g/L).
Unfortunately, her clinical condition deteriorated very quickly. She became confused, encephalopathic, and her Glasgow coma scale (GCS) dropped to 11/15. The patient was transferred to the intensive care unit, where she was intubated and ventilated. She was transfused with blood products and intravenous cefotaxime and metronidazole were given to avoid the risk of spontaneous bacterial peritonitis.
The patient remained haemodynamically stable after the procedure, and could be transferred out of intensive care. However, the recovery from her encephalopathy was much slower, taking around 10 weeks for her indices of hepatic synthetic function to return back to normal.
Treatment for her encephalopathy included L-ornithine L-aspartate, regular human albumin solutions, and bowel cleansing preparations that included lactulose and phosphate enemas. She was discharged 3 months after her initial presentation and remains well.
Renal angiomyolipomata arise from the mesenchymal elements of the kidney2. These tumours consist of a collection of blood vessels, smooth muscle and mature adipose tissue, although a more aggressive subtype also exists that consists of perivascular epitheliod cells [3, 6, 7, 12]. 80% of angiomyolipomata are associated with tuberous sclerosis [2, 6]. In this context, such lesions are typically multiple, bilateral and are associated with rapid growth and an increased risk of haemorrhage [4, 7]. A sporadic and rare form of angiomyolipoma is also found where lesions are usually single, unilateral and generally asymptomatic [2, 11].
Renal angiomyolipomata are commonly found as incidental findings on cross-sectional imaging (ultrasound, CT or MR) . On ultrasound, they usually cast an acoustic shadow, and appear homogeneous with high reflectivity due to their high fat content [1, 6]. On CT, angiomyolipomata have well-defined margins, with a variable proportion of fat and soft tissue, although the former usually predominates . The fat content of these lesions is also well demonstrated on MR .
A fine-needle biopsy or aspiration cytology may be considered on rare occasions where the diagnosis may be in doubt, although there is a potential risk of serious haemorrhage during the procedure. Histology of angiomyolipomata confirms that they are mainly composed of spindle-shaped smooth muscle cells, and the presence of multiple epithelioid cells is found in the more aggressive form [3, 12]. Genetic studies confirm a clonal neoplastic proliferation .
The majority of patients with renal angiomyolipomata are asymptomatic, and it is estimated that over 10 million people worldwide have such lesions . In the minority of patients that are symptomatic, the classic 'Lenk's triad' of symptoms include flank or abdominal pain, a palpable or tender mass and haematuria4. Other symptoms may include fever, vomiting, anaemia, renal failure and hypotension .
Some angiomyolipomata can grow rapidly, up to 4 cm per year . If greater than 4 cm in diameter, these lesions are associated with an increased risk of aneurysmal formation and hence a higher possibility of rupture and haemorrhage [2, 4, 11, 13]. If bleeding presents acutely, it is potentially a life-threatening situation, which may require surgical intervention leading to a possible nephrectomy [7, 11].
In all cases, the aim of treatment is to preserve renal function and to prevent haemorrhage . The current first-line treatment is angiography with selective embolisation and all patients with symptoms should be considered for this intervention [2–4].
The role of prophylactic embolisation is to prevent the possible risk of haemorrhage . It is currently recognized that in angiomyolipomata greater than 4 cm in diameter and the presence of intra-tumoral aneurysmal disease predisposes to an increased risk of bleeding. This is also true for women who intend to become pregnant, on account of haemodynamic changes during pregnancy [4–6, 11].
Surgery is reserved for patients who have had an unsuccessful embolisation. It is also considered where there is a suspicion of malignancy, and in patients with persistent and life-threatening hemorrhages, which could possibly lead to a nephrectomy [4, 7].
It is well recognised that the spectrum of hepatic encephalopathy (HE) varies from minimal encephalopathy, which can only be found by sensitive psychometric tests and imaging modalities, to overt HE, which can manifest as deep coma [8–10]. In the case we report, the patient had previously functioned normally with respect to her cognitive state. However, the episode of overt HE seemed to be caused by haemodynamic instability from the bleeding angiomyolipoma, which is a hitherto unreported risk of these renal lesions.
We presented a rare case where an incidental 4 cm renal angiomyolipoma was found on routine screening, in a patient with known chronic liver disease. Spontaneous haemorrhage from this lesion caused sudden functional hepatic decompensation, which took over 10 weeks for a full recovery.
In view of the potential risks of bleeding and subsequent development of HE, the detection of a 4 cm angiomyolipoma on routine screening should have raised the possibility of prophylactic embolisation, especially in this patient with cirrhosis of the liver.
Although our patient did not have a significant coagulopathy on presentation, prolonged prothrombin times are a major feature of chronic liver disease, particularly during episodes of functional decompensation. This would make patients with coexisting angiomyolipomata more at risk of bleeding, than the general population. We therefore suggest the use of prophylactic embolisation of incidental angiomyolipomata if present, regardless of its size, in all patients with chronic liver disease.
Writteninformed patient consent was obtainedfor publication.
- Wagner BJ, Wong-You-Cheong JJ, Davis CJ: Adult renal hamartomas. Radiographics. 1997, 1: 155-69.View ArticleGoogle Scholar
- Simmons JL, Hussain SA, Riley P, Wallace DM: Management of renal angiomyolipoma in patients with tuberous sclerosis complex. Oncol Reports. 2003, 10: 237-241.Google Scholar
- Unlu C, Lamme B, Nass P, Bolhuis HW: Retroperitoneal haemorrhage caused by a renal angiomyolipoma. Emerg Med J. 2006, 23: 464-465. 10.1136/emj.2005.033191.View ArticlePubMedPubMed CentralGoogle Scholar
- Kunzi T, Walther F, Marti HP, Frey FJ, Vogt B: Intrarenal arterial aneurysms with haematuria in a patient with tuberous sclerosis complex. Nephrol Dialysis Transpl. 2005, 20: 2268-2270. 10.1093/ndt/gfh935.View ArticleGoogle Scholar
- Shah J, Miller M, Patel U, Anson KM: Selective embolisation of bleeding renal angiomyolipoma in pregnancy. J Roy Soc Med. 1999, 92: 414-415.PubMedPubMed CentralGoogle Scholar
- Lewis EL, Palmer JM: Renal angiomyolipoma and massive retroperitoneal haemorrhage during pregnancy. Western J Med. 1985, 143: 675-676.Google Scholar
- Nelson CP, Sanda MG: Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002, 168: 1315-1325. 10.1016/S0022-5347(05)64440-0.View ArticlePubMedGoogle Scholar
- Gerber T, Schomerus H: Hepatic encephalopathy in liver cirrhosis: Pathogenesis, diagnosis and management. Drugs. 2000, 60: 1353-1370. 10.2165/00003495-200060060-00008.View ArticlePubMedGoogle Scholar
- Grover VP, Dresner MA, Forton DM, Counsell S, Larkman DJ, Thomas HC, Taylor-Robinson SD: Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol. 2006, 12: 2969-2978.View ArticlePubMedPubMed CentralGoogle Scholar
- Kircheis G, Wettstein M, Dahl S, Häussinger D: Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metab Brain Dis. 2002, 17: 453-462. 10.1023/A:1021934607762.View ArticlePubMedGoogle Scholar
- Yamakado K, Tanaka N, Nakagawa T: Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology. 2002, 225: 78-82. 10.1148/radiol.2251011477.View ArticlePubMedGoogle Scholar
- Bernardini S, Chabannes E, Algros M, Billerey C, Bittard H: Variants of renal angiomyolipoma: Difficulties in the histological diagnosis. Urologia Internationalis. 2002, 69: 78-81. 10.1159/000064367.View ArticlePubMedGoogle Scholar
- Steiner MS, Goldman SM, Fishman EK, Marshall FF: The natural history of renal angiomyolipoma. J Urol. 1993, 150: 1782-1786.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.